×ÊѶËÑË÷£º [¶©ÔÄ][Ͷ¸å]
ÄúµÄλÖãºÒ½Ò©ÍøÊ×Ò³ > Ò½Ò©×ÊѶ > ÕÐÉÌ¿ìѶ

ÎäÌïÒ©´ú¶¯Á¦Ñ§Ö¸µ¼ÏµÄѪÓѲ¡¹ÜÀí¹¤¾ßmyPKFiT»ñÅú

news.PharmNet.com.cn¡¡2020-11-20¡¡Ò½Ò©Íø¡¡×ֺţº·Å´ó Õý³£

¡¡¡¡ÎäÌïÖйú½ñÈÕÐû²¼£¬Ò©´ú¶¯Á¦Ñ§£¨PK£©Ö¸µ¼ÏµÄAÐÍѪÓѲ¡£¨ÏÈÌìÐÔÄýѪÒò×ÓVIIIȱ·¦£©¹ÜÀí¹¤¾ßmyPKFiT®¾­¹ú¼ÒÒ©Æ·¼à¶½¹ÜÀí¾Ö£¨NMPA£©Åú×¼£¬ÊÊÓÃÓÚ16Ëê¼°ÒÔÉÏ£¨ÌåÖØ45 kg¼°ÒÔÉÏ£©½ÓÊܰÙÒòÖ¹®£¨×¢ÉäÓÃÖØ×éÈËÄýѪÒò×ÓVIII£©ÖÎÁƵÄAÐÍѪÓѲ¡»¼Õß¡£myPKFiT®ÊÇÖйúÊ׸öÖ§³ÖѪÓѲ¡Ò©´ú¶¯Á¦Ñ§£¨PK£©Ö¸µ¼ÏµĹÜÀí¹¤¾ß£¬Ò²ÊǽØÖ¹ÖÁĿǰ¹ú¼ÒÒ©Æ·¼à¶½¹ÜÀí¾ÖΨһÅú×¼µÄ¸öÌ廯Ԥ·ÀFVIII¼ÁÁ¿Ö¸µ¼Èí¼þ£¬¹©ÊìϤѪÓѲ¡AÖÎÁƵÄÖ´ÒµÒ½ÁÆ×¨ÒµÈËÊ¿£¨HCP£©Ê¹ÓᣰÙÒòÖ¹®ÓëmyPKFiT®ÅäºÏʹÓ㬿ÉÕë¶Ôÿλ»¼ÕߵIJ»Í¬ÌØÕ÷ºÍÐèÇ󣬸öÌ廯µ÷ÕûѪÓѲ¡»¼ÕßµÄÄýѪ°ËÒò×Ó£¨FVIII£©ÓÃÁ¿£¬ÎªÖйúѪÓѲ¡»¼Õß¿ªÆô¸öÌ廯ÖÎÁÆÐÂʱ´ú£¬ÖúÁ¦ÊµÏÖ×ÔÓÉÈËÉú¡£

 

 

¡¡¡¡ÑªÓѲ¡ÊÇÒ»ÖÖÒþÐÔÒÅ´«ÐÔº±¼û²¡£¬Ö÷ÒªÓÉÓÚ»¼ÕßÌåÄÚȱ·¦ÄýѪÒò×Óµ¼ÖÂÄýѪÕϰ­¡£Ä¿Ç°£¬ÖйúÔ¼ÓÐ13.6ÍòÃû»¼Õß1£¬ÆäÖÐAÐÍѪÓѲ¡Ô¼Õ¼×ÜÊýµÄ80%-85%1¡£ÆäÖ¢×´Ö÷Òª±íÏÖΪ¹Ø½Ú¡¢¼¡ÈâºÍÉ×éÖ¯³öѪ£¬»òÕßÊÇ賦µÀ¡¢ÖÐÊàÉñ¾­ÏµÍ³µÈÄÚ²¿ÔàÆ÷³öѪ¡£Èç¹û»¼Õß·´¸´³öѪÇÒ²»¼°Ê±ÖÎÁƵϰ£¬»áµ¼Ö¹ؽڻûÐλò¼ÙÖ×ÁöÐγɣ¬ÑÏÖØÕß¿ÉΣ¼°ÉúÃü2¡£ÓëÐí¶àÒÅ´«ÐÔ¼²²¡²»Í¬µÄÊÇ£¬ÑªÓѲ¡»¼ÕßÖ»Ðè½ÓÊܳ¤ÆÚ¹æÂÉÐԵĹ淶»¯ÖÎÁÆ£¬ÓÐÍûʵÏÖ“Áã³öѪ”£¬»Ø¹éÕý³£Éú»î¡£

 

¡¡¡¡È»¶ø»ùÓÚ¹úÄÚµÄʵ¼ÊÇé¿ö£¬Ä¿Ç°ÆÕ±é²ÉÓõͼÁÁ¿µÄ¹æ·¶ÖÎÁÆ·½°¸¡£ÁÙ´²Êµ¼ù±íÃ÷£¬ËäÈ»¸Ã·½°¸ÄÜÃ÷ÏÔ¼õÉÙ»¼Õß³öѪ£¬µ«²¢²»ÄܼõÉٹؽڲ¡±äµÄ·¢ÉúÇÒÈÔÓгöѪµÄÇé¿ö·¢Éú2¡£2020ÊÀ½çѪÓѲ¡ÁªÃË£¨World Federation of Hemophilia£©Ö¸ÄÏÖ¸³ö£¬Ô¤·ÀÖÎÁÆÓ¦É趨¸ü¸ß¹ÈˮƽĿ±ê£¬×îÖÕ×·Çó“Áã³öѪ”¡£ÔÚ¹Èˮƽ1%µÄÇé¿öÏ£¬»¼ÕßÈÔ»áÓгöѪ·çÏÕ£¬Òò´Ë´ó¶àÊýÁÙ´²Ò½ÉúÇãÏòÓÚ´ïµ½¸ü¸ßµÄ¹Èˮƽ(£¾3%-5%£¬»òÕ߸ü¸ß)3¡£¶Ô´Ë£¬¡¶ÑªÓѲ¡ÖÎÁÆÖйúÖ¸ÄÏ£¨2020Äê°æ£©¡·½¨Ò飬¿É¸ù¾Ý»¼ÕßµÄÄêÁä¡¢³öѪ±íÐÍ¡¢Ò©´ú¶¯Á¦Ñ§£¨PK£©ÌØÕ÷ÒÔ¼°Éú»î·½Ê½µÈÇé¿ö£¬Öƶ¨Êʺϻ¼ÕßµÄ×î¼Ñ¸öÌ廯·½°¸£¬µ÷½Ú×¢ÉäÄýѪÒò×ӵļÁÁ¿¡¢Å¨¶ÈºÍƵÂÊ£¬ÓÐЧ±ÜÃâδµÃµ½³ä·ÖÖÎÁÆ»òÖÎÁƹý¶ÈµÄÇé¿ö4¡£

Öйúҽѧ¿ÆÑ§ÔºÑªÒº²¡Ò½ÔºÑªË¨Ö¹ÑªÕïÁÆÖÐÐÄÖ÷ÈÎÑîÈʳؽÌÊÚ

 

¡¡¡¡“½üÄêÀ´£¬Ëæ×Åҽѧ¼¼ÊõºÍÖÎÁÆÁìÓòµÄ¸ïл»´ú£¬ÖйúѪÓѲ¡ÕïÁƹ¤×÷ÒÑÈ¡µÃ³¤×ã½ø²½£¬Õý´Ó´«Í³µÄ°´ÐèÖÎÁÆ·½Ê½×ªÎª¸ü»ý¼«ºÍ¸ü¼Ó¸öÌ廯µÄÖÎÁÆÄ£Ê½¡£”Öйúҽѧ¿ÆÑ§ÔºÑªÒº²¡Ò½ÔºÑªË¨Ö¹ÑªÕïÁÆÖÐÐÄÖ÷ÈÎÑîÈʳؽÌÊÚ˵µÀ£¬“ѪÓѲ¡Ô¤·ÀÖÎÁƵı¾ÖÊÊÇÐèÒªÒ»ÖÖ³¤ÆÚ¡¢¹æÂÉÐÔµÄÌæ´úÖÎÁÆ¡£Îҷdz£¸ßÐË¿´µ½ÖйúÊ׸öÒ©´ú¶¯Á¦Ñ§Ö¸µ¼ÏµĹÜÀí¹¤¾ß»ñÅú£¬Õ⽫Ϊÿһλ»¼ÕßÌṩ¸öÌ廯¡¢¿É³ÖÐøµÄÖÎÁƹÜÀí£¬°ïÖú»¼Õß°ÚÍѼ²²¡Êø¸¿£¬³©Ïí×ÔÓÉÈËÉú¡£”

 

¡¡¡¡myPKFiT®Ö¸µ¼ÏµİÙÒòÖ¹®£¨×¢ÉäÓÃÖØ×éÈËÄýѪÒò×ÓVIII£©ÖÎÁÆ£¬¿É½µµÍ³öѪ·çÏÕ£¬ÓÅ»¯ÖÎÁÆÐ§¹ûºÍÒ©Îï¿É¼°ÐÔ£¬´Ó¶øÌáÉý»¼ÕßÖÎÁÆÐÅÐÄ¡¢¸ÄÉÆÒÀ´ÓÐÔ¡£myPKFiT®Ê¹Óþ­ÑéÖ¤µÄ±´Ò¶Ë¹·½·¨£¬²¢»ùÓÚ2,000¶à·Ý°ÙÒòÖ¹®Ê¹ÓÃÕßѪҺÑù±¾Êý¾Ý½¨Ä££¬Êý¾Ýרһ¿É¿¿¡£¸ù¾ÝÒ»ÏîUK-PKÑо¿µÄÖÐÆÚ·ÖÎöÊý¾ÝÏÔʾ£¬PKÖ¸µ¼ÏµĹ淶»¯ÖÎÁÆÊ¹Áã³öѪ»¼Õß±ÈÀýÌáÉýÖÁ50%£¬»¼ÕßÒÀ´ÓÐÔÌáÉý92.5%5¡£ÖÎÁÆ·ÑÓ÷½Ã棬¸ù¾ÝÒ»Ïî±È½ÏÑо¿ÏÔʾ£¬Óë±ê×¼ÖÎÁÆÏà±È£¬PKÖ¸µ¼ÏµÄÖÎÁƿɽµµÍÕûÌåÖÎÁÆ·ÑÓõÄ10.67%6¡£

 

¡¡¡¡ÎäÌïÖйú×ܲõ¥¹úºé±íʾ£º“·Ç³£¸ßÐË¿´µ½myPKFiT®Õâ¿î¹ú¼ÊÏȽøµÄѪÓѲ¡¸öÌ廯ÖÎÁƹÜÀíÈí¼þÔÚÖйú»ñÅú£¬ÎªÖйú»¼ÕßÌṩ¶¨ÖÆ»¯µÄ¼²²¡¹ÜÀí·½°¸£¬°ïÖúËûÃǻعéÕý³£Éú»î¡£×÷Ϊº±¼û²¡ÁìÓòµÄÈ«ÇòÁ캽Õߣ¬ÎäÌïÔÚѪÓѲ¡ÁìÓòÓÐ×ÅÓÆ¾ÃµÄÀúÊ·´«³ÐºÍ¾­ÑéÀÛ»ý£¬Ê¼ÖÕ»ý¼«ÒýÁìѪÓѲ¡¸öÌ廯ÖÎÁÆÐÂʱ´úµÄµ½À´¡£Î´À´£¬ÎäÌォ±ü³Ð‘»¼ÕßΪÏÈ’µÄºËÐÄÀíÄÃÜÇйØ×¢Öйúº±¼û²¡»¼Õߨ½´ýÂú×ãµÄÐèÇ󣬼ÓËÙÒýÈë¸ü¶àÈ«ÇòÊ×´´¡¢Í¬Àà×îÓŵĴ´ÐÂÁÆ·¨£¬Îª¸ÄÉÆÖйúº±¼û²¡ÕïÁÆÏÖ×´¡¢Ìá¸ß»¼ÕßÉú»îÖÊÁ¿³ÖÐø¹±Ï×ÎÒÃǵÄÁ¦Á¿¡£”

¡¡¡¡²Î¿¼×ÊÁÏ

¡¡¡¡1. The Prevalence of Hemophilia in Mainland China: a systematic review and meta-analysis, Southeast Asian J Trop Med Public Health. 2014 Mar;45(2):455-66

¡¡¡¡2. ¡¶º±¼û²¡ÕïÁÆÖ¸ÄÏ£¨2019°æ£©¡·£¬ÈËÃñÎÀÉú³ö°æÉ磬2019, 177

¡¡¡¡3. ¿ªÆôѪÓѲ¡¸öÌ廯ÖÎÁÆÐÂʱ´ú£¬ÑªÒºÇ°ÑØ£¬2020Äê10ÔÂ10ÈÕ£¬https://mp.weixin.qq.com/s/CyA2ixwY1xeo03qkZ10lNA

¡¡¡¡4. ¡¶ÑªÓѲ¡ÖÎÁÆÖйúÖ¸ÄÏ(2020Äê°æ)¡·£¬ÖлªÑªÒºÑ§ÔÓÖ¾£¬2020,41 (2020-04-16).

¡¡¡¡5. UKPK trial interim analysis: Use of Pharmacokinetic intervention to optimise Factor VIII prophylaxis in severe haemophilia A£¬https://www.postersessiononline.eu/173580348_eu/congresos/WFH2018/aula/-T-MP_87_WFH2018.pdf

¡¡¡¡6. PK-driven prophylaxis versus standard prophylaxis: When a tailored treatment may be a real and achievable cost-saving approach in children with severe hemophilia A£¬ https://pubmed.ncbi.nlm.nih.gov/28692842/

¡¾·µ»Ø¶¥²¿¡¿¡¾´òÓ¡¡¿¡¾¹Ø±Õ¡¿

¡¾°æÈ¨ÉùÃ÷¡¿±ü³Ð»¥ÁªÍø¿ª·Å¡¢°üÈݵľ«Éñ£¬Ò½Ò©Íø»¶Ó­¸÷·½(×Ô)ýÌå¡¢»ú¹¹×ªÔØ¡¢ÒýÓÃÎÒÃÇÔ­´´ÄÚÈÝ£¬µ«ÒªÑϸñ×¢Ã÷À´Ô´Ò½Ò©Íø£»Í¬Ê±£¬ÎÒÃdz«µ¼×ðÖØÓë±£»¤ÖªÊ¶²úȨ£¬Èç·¢ÏÖ±¾Õ¾ÎÄÕ´æÔÚ°æÈ¨ÎÊÌ⣬·³Ç뽫°æÈ¨ÒÉÎÊ¡¢ÊÚȨ֤Ã÷¡¢°æÈ¨Ö¤Ã÷¡¢ÁªÏµ·½Ê½µÈ£¬·¢ÓʼþÖÁpharmnet@netsun.com£¬ÎÒÃǽ«µÚһʱ¼äºËʵ¡¢´¦Àí¡£

·µ»ØÒ½Ò©×ÊѶÊ×Ò³

ʳҩ·¨¹æAPP

ÖÐÒ½Ò©APP